title: [Treatment options for chronic hepatitis C virus infection].
abstract: BACKGROUND
  The incidence of chronic hepatitis C virus (HCV) infection is rather high. Its most frequent consequences are chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
  In treatment of chronic HCV infection, interferons have antiviral, anriproliferative, and immunoregulatory action. Within the cell, they induce protein synthesis, inhibiting viral replication. The most important among them are RNA dependent protein kinase, and eukaryotic initiation factor. However, viral proteins prevent their phosphorylation and activation. In order to overcome this problem, treatment is prolonged, higher doses of lFN are used, as well as induction therapy. The optimal period for viral response is 52 weeks, while induction therapy has shown controversial results.
authors.affiliation: Specijalisticka ordinacja "Dr Bojić", Beograd. drbojic@net.yu
authors.forename: Ivanko
authors.initials: I
authors.lastname: Bojić
authors.forename: Ljubisa
authors.initials: L
authors.lastname: Dokić
authors.forename: Svetlana
authors.initials: S
authors.lastname: Minić
mesh_terms: D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*
chemical_list: D007372:Interferons